Last Updated: November 9, 2026

Aurobindo Pharma Usa Company Profile

« Back to Dashboard


What is the competitive landscape for AUROBINDO PHARMA USA

AUROBINDO PHARMA USA has sixty-eight approved drugs.

There are two tentative approvals on AUROBINDO PHARMA USA drugs.

Summary for Aurobindo Pharma Usa
US Patents:0
Tradenames:58
Ingredients:57
NDAs:68
Patent Litigation for Aurobindo Pharma Usa: See patent lawsuits for Aurobindo Pharma Usa
PTAB Cases with Aurobindo Pharma Usa as petitioner: See PTAB cases with Aurobindo Pharma Usa as petitioner

Drugs and US Patents for Aurobindo Pharma Usa

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Usa MECLIZINE HYDROCHLORIDE meclizine hydrochloride TABLET;ORAL 202640-003 Sep 17, 2012 AA RX No No ⤷  Start Trial ⤷  Start Trial
Aurobindo Pharma Usa AZITHROMYCIN azithromycin TABLET;ORAL 065360-001 Jan 8, 2007 DISCN No No ⤷  Start Trial ⤷  Start Trial
Aurobindo Pharma Usa ATENOLOL AND CHLORTHALIDONE atenolol; chlorthalidone TABLET;ORAL 074203-002 Oct 31, 1993 DISCN No No ⤷  Start Trial ⤷  Start Trial
Aurobindo Pharma Usa MECLIZINE HYDROCHLORIDE meclizine hydrochloride TABLET;ORAL 202640-002 Sep 17, 2012 AA RX No No ⤷  Start Trial ⤷  Start Trial
Aurobindo Pharma Usa MECLIZINE HYDROCHLORIDE meclizine hydrochloride TABLET;ORAL 202640-001 Sep 17, 2012 AA RX No No ⤷  Start Trial ⤷  Start Trial
Aurobindo Pharma Usa TIZANIDINE HYDROCHLORIDE tizanidine hydrochloride TABLET;ORAL 076282-001 Dec 16, 2003 AB RX No No ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Subscribe to access the full database, or Start Trial

Expired US Patents for Aurobindo Pharma Usa

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Aurobindo Pharma Usa MAXZIDE hydrochlorothiazide; triamterene TABLET;ORAL 019129-001 Oct 22, 1984 4,105,783 ⤷  Start Trial
Aurobindo Pharma Usa MAXZIDE-25 hydrochlorothiazide; triamterene TABLET;ORAL 019129-003 May 13, 1988 4,444,769 ⤷  Start Trial
Aurobindo Pharma Usa MAXZIDE hydrochlorothiazide; triamterene TABLET;ORAL 019129-001 Oct 22, 1984 4,444,769 ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Subscribe to access the full database, or Start Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links